479 related articles for article (PubMed ID: 38454419)
1. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
2. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
Catanzaro E; Feron O; Skirtach AG; Krysko DV
Front Immunol; 2022; 13():925290. PubMed ID: 35844506
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
7. The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells.
Zhang Y; Yu W; Chen M; Zhang B; Zhang L; Li P
Nanoscale; 2023 Jul; 15(29):12137-12156. PubMed ID: 37377098
[TBL] [Abstract][Full Text] [Related]
8. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
9. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
[TBL] [Abstract][Full Text] [Related]
10. Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example.
Meng Q; Ding B; Ma P; Lin J
Small Methods; 2023 May; 7(5):e2201406. PubMed ID: 36707416
[TBL] [Abstract][Full Text] [Related]
11. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
12. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
13. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ
Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063
[TBL] [Abstract][Full Text] [Related]
14. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors.
Xie B; Zhao H; Ding YF; Wang Z; Gao C; Li S; Zhang K; Ip SW; Yu H; Wang R
Adv Sci (Weinh); 2023 Dec; 10(34):e2304407. PubMed ID: 37850572
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment.
Wan S; Zhang G; Liu R; Abbas MN; Cui H
Cell Commun Signal; 2023 May; 21(1):115. PubMed ID: 37208730
[TBL] [Abstract][Full Text] [Related]
16. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic cell death in cancer immunotherapy.
Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
[TBL] [Abstract][Full Text] [Related]
18. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
Immunol Rev; ; . PubMed ID: 29027218
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
